טוען...
Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken
Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...
שמור ב:
| הוצא לאור ב: | Microb Pathog |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Ltd.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127065/ https://ncbi.nlm.nih.gov/pubmed/29635053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.micpath.2018.04.012 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|